Daily BriefsJapan

Japan: Mercari Inc, Sony Corp, Nintendo Co Ltd, Nikkei 225, Softbank Corp, Takeda Pharmaceutical, Tokyo Stock Exchange Tokyo Price Index Topix, Kura Sushi Inc, Tosho Co Ltd and more

In today’s briefing:

  • Mercari – Margin Miss Not Beat
  • TOPIX-Nikkei Skew Trade Starting to Work Nicely
  • Nintendo – Solid Beat Should Confirm Early Nov Bottom
  • Nikkei 225 Fails to Breach the Zone of Resistance
  • Softbank Corp (Buy) – Q3 21 Results Reaction: Weak Consumer Mobile but FY Targets in Sight
  • Takeda: Key Drugs Continue Growth and Upgrade to Guidance; Pipeline Progress Despite Recent Setbacks
  • Japan’s Governance: TOPIX Reform Update (2) – Change in Calculation Method of Floating Share Ratio
  • Mercari – Don’t Panic Sell
  • Kura Sushi (2695): Relay from Demon Slayer to BTS. Winning with Entertainment Value
  • Tosho (8920): Solid 3Q OP; Announced Upward Revision of Guidance on Property Sales

Mercari – Margin Miss Not Beat

By Mio Kato

  • We got this wrong, expecting a beat on margins in spite of weak GMV, whereas Mercari actually fell into the red for the first time in six quarters. 
  • The culprit is extremely aggressive promotional spend which looks to have hit all time highs in both Japan and the US. 
  • The shift to an investment stance is not in and of itself a bad thing but the growth relative to the spend is disappointing so far.

TOPIX-Nikkei Skew Trade Starting to Work Nicely

By Mio Kato

  • After initially grinding up slowly but underperforming the Nikkei our suggested skew trade gave up ground during the new year sell off.
  • It did so slowly, however and was outperforming Nikkei when last we checked despite being down slightly. 
  • Thankfully, a lot of the idiosyncratic volatility hurting the skew trade has reversed now and it is positive and outperforming Nikkei consistently.

Nintendo – Solid Beat Should Confirm Early Nov Bottom

By Mio Kato

  • Nintendo posted an impressive top line for 3Q at ¥696bn in revenue vs. consensus at ¥641bn for an 8.6% beat. 
  • OP of ¥253bn beat consensus by 16.9% suggesting that sell side analysts do not understand Nintendo’s new profit structure. 
  • The stock has been resilient since bottoming in early November and we expect strong performance to continue.

Nikkei 225 Fails to Breach the Zone of Resistance

By Shyam Devani

  • The nasty “squeeze” up in the Nikkei 225 has so far stalled within the zone of resistance at 27,293-27,629
  • A move back below 26,954 would add to the bearish bias seen overall
  • Medium to long term supports and target area comes in closer to 24,500

Softbank Corp (Buy) – Q3 21 Results Reaction: Weak Consumer Mobile but FY Targets in Sight

By Kirk Boodry

  • Results were pretty much in line with expectations as growth from Z Holdings and Enterprise sales offset consumer mobile weakness.
  • The company is slightly behind the pace needed to meet its full-year operating profit target but appears confident on meeting FY21 and FY22 commitments
  • Management reports that cashless app PayPay generated ¥21bn in Q3 revenue as SME monetization kicked in

Takeda: Key Drugs Continue Growth and Upgrade to Guidance; Pipeline Progress Despite Recent Setbacks

By Shifara Samsudeen, ACMA, CGMA

  • Takeda announced 3QFY03/2022 results today. Reported revenue grew 7.7% YoY to JPY901.3bn (vs consensus JPY850.5bn) and OP declined 18.6% YoY to JPY116.5bn (vs consensus JPY115.6bn) due to divestitures.
  • Revenue from Top 14 key drugs grew 21.2% YoY, while revenue from top-seller Entyvio grew 24.2% YoY during the quarter.
  • Takeda has upgraded its previous guidance for full-year FY03/2022. The company continues to progress with drug development. Two of its products were approved during the last 6-months.

Japan’s Governance: TOPIX Reform Update (2) – Change in Calculation Method of Floating Share Ratio

By Aki Matsumoto

  • This article will focus on TOPIX reform regarding policy shares. The biggest change in the way TOPIX’s float ratio is calculated is the exclusion of policy shares from TOPIX float.
  • Companies with a large cross-shareholdings will see a downward impact on their stock prices. We expect to see a move to reduce policy holdings by the end of March.
  • It is also expected that there will be a move to transfer policy-holding shares to deemed-holding shares, which are considered floating shares. We should keep close eyes on such moves.

Mercari – Don’t Panic Sell

By Mio Kato

  • Mercari opened down 11.7% and has now recovered to be down “only” 8.5%. 
  • While our impression of results yesterday was negative the intensity of the move is overdone in our view. 
  • We still believe that momentum is likely to be muted for a while but the current price is not unattractive.

Kura Sushi (2695): Relay from Demon Slayer to BTS. Winning with Entertainment Value

By Mita Securities

  • On February 3, Kura Sushi (2695, the company) disclosed monthly data for January (on a preliminary basis)
  • The company ran a special fair using high-end ingredients in early January and has been running a “BT21” campaign from January to February.
  • BT21 is a globally popular character brand created through a collaboration between LINE FRIENDS and BTS (Bangtan Sonyeondan)

Tosho (8920): Solid 3Q OP; Announced Upward Revision of Guidance on Property Sales

By Mita Securities

  • Tosho (8920, the company) announced 3Q FY3/22 results and an upward revision of its full- year guidance.

  • Recovery progressed in 3Q mainly in the hotel business

  • The company announced a revision to its FY3/22 full-year guidance, raising its OP guidance from 2.0bn yen to 4.4bn yen


Before it’s here, it’s on Smartkarma